Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Merdury Biopharmaceutical Corporation (6932) Income Statement

Merdury Biopharmaceutical Corporation Income Statement

Last quarter (Q2 2026), Merdury Biopharmaceutical Corporation's total revenue was NT$0.00, a decrease of 100.00% from the same quarter last year. In Q2, Merdury Biopharmaceutical Corporation's net income was NT$-22.71M. See Merdury Biopharmaceutical Corporation’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 0.00NT$ 4.96MNT$ 1.03MNT$ 2.68MNT$ 0.00
NT$ -11.64MNT$ 4.18MNT$ 592.00KNT$ 1.17MNT$ -972.00K
NT$ 56.91MNT$ 58.23MNT$ 46.28MNT$ 32.07MNT$ 5.30M
Depreciation and AmortizationNT$ 11.64MNT$ 7.45MNT$ 4.07MNT$ 2.75MNT$ 972.00K
NT$ -56.91MNT$ -42.27MNT$ -39.03MNT$ -28.10MNT$ -4.33M
NT$ -68.55MNT$ -54.04MNT$ -45.69MNT$ -30.85MNT$ -5.30M
NT$ 1.38MNT$ 3.51MNT$ 1.87MNT$ -352.00KNT$ -10.00K
NT$ -67.17MNT$ -50.53MNT$ -43.82MNT$ -31.25MNT$ -5.31M
NT$ -67.23MNT$ -50.57MNT$ -43.82MNT$ -31.25MNT$ -5.31M
Per Share Metrics
Basic EPSNT$ -0.16NT$ -0.12NT$ -0.11NT$ -0.08NT$ -0.02
Diluted EPSNT$ -0.16NT$ -0.12NT$ -0.11NT$ -0.08NT$ -0.02
Weighted Average Shares Outstanding420.20M415.98M398.33M378.74M278.30M
Weighted Average Shares Outstanding (Diluted)420.20M421.40M398.33M378.74M278.30M

Currency in TWD

Merdury Biopharmaceutical Corporation Earnings and Revenue History

-80M-40M040M-4500 %-3000 %-1500 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin